Compounds and methods for promoting cellular health and treatment of cancer

1. A pharmaceutical composition consisting essentially of:

15 mg extract of Gynostemma pentaphyllum;

11.25 mg extract of the root of Astragalus;

9.62 mg extract of the fruit of Ligustrum;

25 mg extract of the fruit of Schisandra;

7.5 mg of extract of Rhodiola crenulata;

35 mg of extract of Punica granatum comprising about 70% by weight ellagic acid;

7.5 mg of extract of Polygonum cuspidatum comprising about 15% by weight resveratrol;

25 mg quercetin;

about 180 mg of phytosterol complex comprising at least 50% by weight beta-sitosterol and further comprising beta-sitostanol;

37.19 mg inositol hexaphosphate;

15 mg trimethylglycine;

6 mg oligomeric proanthocyanidin grape seed extract;

2.5 mg Solanum lycopersicum extract comprising about 15% lycopene;

2.5 mg powdered 1:1 complex of zinc and methionine;

0.25 mg copper as gluconate; and

25 mg lecithin powder.